Pipeline

Our programs, end-to-end.

An interactive view of our preclinical and clinical-stage programs, organised by therapeutic area.

Drug Pipeline

Programs in development

Tap any stage to see program detail. Stages reflect the most advanced ongoing activity for that program.

Program
Discovery
Preclinical
IND Filing
Phase I/II

  • NYB-MET-001

    Metabolic Health
    current

  • NYB-INF-002

    Inflammation
    current

  • NYB-ONC-003

    Oncology
    current

Discovery

Target ID, hit-finding, lead identification.

Preclinical

Lead optimisation, in vivo PK/PD, tox studies.

IND Filing

IND-enabling studies and regulatory submission.

Phase I/II

First-in-human safety and proof-of-concept efficacy.